JohnsonandJohnson | Financial Buzz

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Johnson & Johnson Files for Emergency Use Authorization

Rebecca Urena02/05/2021

3303

Johnson and Johnson (NYSE: JNJ) has requested emergency use authorization from the Food and Drug Administration for its single-dose COVID19 vaccine. The company recently shared data demonstrating its vaccine...

Healthcare Investing News Life Style Market News Medical Use Pharmaceutical The Market Buzz Your Environment

J&J Single-Dose Covid Vaccine 66% Effective

Rebecca Urena01/29/202101/29/2021

3029

Johnson & Johnson (NYSE: JNJ) announced Friday that its single-dose coronavirus vaccine was currently 66% effective against Covid-19. Nevertheless, the vaccine seems to be less efficient when it comes...

Investing News Life Style Market News Medical Use Pharmaceutical Products Technology The Market Buzz Your Environment

Analysts Are Optimistic on Johnson & Johnson’s Covid Vaccine

Rebecca Urena01/11/202101/11/2021

3478

Johnson & Johnson (NYSE: JNJ) is actively in a phase 3 clinical trial involving 45,000 participants for its one dose Covid-19 vaccine and analysts are optimistic on the end...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical The Market Buzz Your Environment

Johnson & Johnson Enlists 45,000 Participants in Late-Stage Covid Vaccine Trial

Rebecca Urena12/18/2020

3217

Johnson & Johnson (NYSE: JNJ) announced Thursday it has enrolled approximately 45,000 participants for the first late-stage trial of its COVID-19 single-dose vaccine. The company anticipates provisional data by...

Biotechnology Healthcare Investing News Life Style Market News Science Technology The Market Buzz Your Environment

Johnson & Johnson’s COVID-19 Vaccine Prevents Illness in Hamsters

Rebecca Urena09/04/202009/04/2020

3403

Johnsons & Johnson’s (NYSE: JNJ) possible coronavirus vaccine, currently being tested, has prevented serious diseases in a limited group of Syrian golden hamsters, according to the company. The multinational...

Healthcare Investing News Market News

Johnson & Johnson to Buy Momenta Pharmaceutical for $6.5 Billion

Rebecca Urena08/19/2020

3670

Johnson & Johnson (NYSE: JNJ) announced Wednesday it would be purchasing Momenta Pharmaceuticals for USD6.5 Billion in cash as it strives to grow its portfolio of drugs for autoimmune...

Biotechnology Healthcare Investing News Life Style Market News Pharmaceutical The Market Buzz Your Environment

Johnson & Johnson to Deliver U.S 100 Million Doses of Coronavirus Vaccine

Rebecca Urena08/05/2020

5465

Johnson & Johnson (NYSE: JNJ) revealed Wednesday that it has reached an agreement with the U.S. to provide 100 million doses of it COVID-19 vaccine for a sum of...

Healthcare Investing News Market News Technology The Market Buzz

J&J Profit Plummets 35%

Rebecca Urena07/16/202007/16/2020

4894

Johnson & Johnson (NYSE: JNJ) second quarter profit plummets 35% amid the coronavirus pandemic. The lack of demand for beauty products and medical equipment has taken a toll on...

Tag: JohnsonandJohnson